SANTA ROSA BEACH, Fla. and SINGAPORE, Oct. 10, 2023 – Fibronostics, a global leader in non-invasive, AI-driven diagnostic testing for *MAFLD/MASH patients, announced today a strategic partnership with Stone Diagnostics, a leading provider of laboratory services in the United States. Stone Diagnostics will provide Physicians … Read More